Nano HoldingsNano Holdings, Inc.4571東証グロース医薬品FY ending Mar 2026, consolidated, J-GAAP
Nano Holdings brought in ¥313.3M in revenue.
It lost about ¥416 for every ¥100 of sales at the operating level.
Revenue changed -43.3% from the prior year.
FY ending Mar 2020 → FY ending Mar 2021
FY ending Mar 2020 → FY ending Mar 2021
For every ¥100 Nano Holdings sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.